Hepatitis Delta Infections in Hemophiliacs

NCT00005305 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 61

Last updated 2016-06-14

No results posted yet for this study

Summary

To elucidate the role of hepatitis delta virus (HDV) in the development of chronic liver disease in patients with hemophilia.

Conditions

Interventions

OTHER

No interventions - observational study

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH
  • University of North Carolina, Chapel Hill

    lead OTHER

Principal Investigators

  • Stanley M Lemon, MD · University of North Carolina, Chapel Hill

Eligibility

Max Age
100 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
1987-09-30
Primary Completion
1991-09-30
Completion
1991-09-30

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00005305 on ClinicalTrials.gov